NDC 68788-8763-01 - Dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8763
- Requested NDC
- 68788-8763-01
- Package NDCs from labels
- 68788-8763-1, 68788-8763-2, 68788-8763-3, 68788-8763-0, 68788-8763-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-01-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Tablets, USP | Preferred Pharmaceuticals Inc. | 2026-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8763-0 | Dexamethasone | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 68788-8763-1 | Dexamethasone | 12 in 1 BOTTLE | TABLET | 12 | 2 | |
| 68788-8763-2 | Dexamethasone | 21 in 1 BOTTLE | TABLET | 21 | 2 | |
| 68788-8763-3 | Dexamethasone | 30 in 1 BOTTLE | TABLET | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8763 | DEXAMETHASONE TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 4 package rows | 20241113_64577454-d49e-4180-99e6-8461f74b0221.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8763-0 | EA - Each | 68788-8763 | 73b37d2c-7deb-428c-966c-e729ce80b518 | 1 | 2025-02-10 |
| 68788-8763-1 | EA - Each | 68788-8763 | 2cbcf06f-719b-4db2-87d1-69b48817d904 | 1 | 2025-02-10 |
| 68788-8763-2 | EA - Each | 68788-8763 | bd7d0917-7dfc-4946-9fe8-091d2e72eb00 | 1 | 2025-02-10 |
| 68788-8763-3 | EA - Each | 68788-8763 | 4e9107e1-bc1f-41cb-b0d3-9f5bef02d973 | 1 | 2025-02-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEXAMETHASONE | DEXAMETHASONE | NuCare Pharmaceuticals, Inc. | 4a808dd5-35b7-e879-e063-6394a90a0bf7 | 2026-02-10 | Warnings, Adverse reactions | 197580 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | 0a0db8e7-8474-3d08-e063-6294a90af3f5 | 2026-02-06 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bryant Ranch Prepack | e830be9d-0a8c-4712-93c6-284c208d6f0d | 2026-02-05 | Warnings, Adverse reactions | ANDA216282 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bryant Ranch Prepack | b3217057-5945-452c-aa99-ab696fd8b5e7 | 2026-02-04 | Warnings, Adverse reactions | 197580 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | A-S Medication Solutions | cdd9086d-821f-4ac8-bc49-f1869dffb150 | 2026-01-29 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | c3b6004a-8cfc-d5f8-e053-2a95a90a3efb | 2026-01-21 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 64577454-d49e-4180-99e6-8461f74b0221 | 2026-01-20 | Warnings, Adverse reactions | ANDA216282 68788-8763-2 68788-8763-1 68788-8763-3 68788-8763-0 68788-8763 68788876301 343033 86f71920-d9ff-41d1-a70e-b90c446f6db6 64577454-d49e-4180-99e6-8461f74b0221 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Preferred Pharmaceuticals Inc. | e42d4837-77c2-40c3-8705-20966a51a822 | 2026-01-19 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| DEXAMETHASONE | DEXAMETHASONE | Bryant Ranch Prepack | 075717e3-be2a-4bb3-bead-492761bfb287 | 2026-01-09 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Hemady | DEXAMETHASONE | Edenbridge Pharmaceuticals LLC. | 6b9cf32c-6d60-4853-bbfd-2304ffc2c129 | 2026-01-09 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Anti-Smoking II Drops 2008 | ANTI-SMOKING II DROPS | Professional Complementary Health Formulas | 8e64a0eb-4673-42e3-8387-7248d3855787 | 2026-01-08 | Warnings | C151H8M554 |
| Large Intestine Formula 2103 | LARGE INTESTINE FORMULA | Professional Complementary Health Formulas | 532eb4c6-0f3f-4853-89e2-43168e118d65 | 2026-01-08 | Warnings | XM0M87F357 |
| Substance Abuse Drops 2063 | SUBSTANCE ABUSE DROPS | Professional Complementary Health Formulas | 61f8263d-6f72-442f-a09e-57daf7226cc7 | 2026-01-08 | Warnings | C151H8M554 |
| Anti-Smoking I Drops 2007 | ANTI-SMOKING I DROPS | Professional Complementary Health Formulas | 1c6b5b98-971d-442a-b9eb-37f65409a521 | 2026-01-08 | Warnings | C151H8M554 |
| Glucose Drops 2031 | GLUCOSE DROPS | Professional Complementary Health Formulas | 21de3b86-be2b-4f71-9384-78ebc42ec087 | 2026-01-08 | Warnings | C151H8M554 |
| Geopathic Stress Drops 2096 | GEOPATHIC STRESS DROPS | Professional Complementary Health Formulas | 7d7302b8-3959-4e1e-ad1f-88d265ba9d32 | 2026-01-08 | Warnings | XM0M87F357 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | A-S Medication Solutions | adcc540e-9275-4a7c-918a-36fa2314acd2 | 2026-01-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Ciprofloxacin and dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Redpharm Drug | 2fd20fcb-222c-bd38-e063-6294a90ac9cd | 2025-12-27 | Warnings, Adverse reactions | 7S5I7G3JQL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.